These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system. Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386 [TBL] [Abstract][Full Text] [Related]
11. Cuprizone-induced graded oligodendrocyte vulnerability is regulated by the transcription factor DNA damage-inducible transcript 3. Fischbach F; Nedelcu J; Leopold P; Zhan J; Clarner T; Nellessen L; Beißel C; van Heuvel Y; Goswami A; Weis J; Denecke B; Schmitz C; Hochstrasser T; Nyamoya S; Victor M; Beyer C; Kipp M Glia; 2019 Feb; 67(2):263-276. PubMed ID: 30511355 [TBL] [Abstract][Full Text] [Related]
12. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination. Tanaka T; Murakami K; Bando Y; Yoshida S J Neurochem; 2013 Oct; 127(2):259-70. PubMed ID: 23647102 [TBL] [Abstract][Full Text] [Related]
13. Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination. Hibbits N; Yoshino J; Le TQ; Armstrong RC ASN Neuro; 2012 Oct; 4(6):393-408. PubMed ID: 23025787 [TBL] [Abstract][Full Text] [Related]
14. 17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss. Taylor LC; Puranam K; Gilmore W; Ting JP; Matsushima GK Neurobiol Dis; 2010 Aug; 39(2):127-37. PubMed ID: 20347981 [TBL] [Abstract][Full Text] [Related]